Management of Neuroendocrine Tumors of the Pancreas and Digestive Tract

From Surgery to Targeted Therapies: A Multidisciplinary Approach

  • Eric Raymond
  • Sandrine Faivre
  • Philippe Ruszniewski

Table of contents

  1. Front Matter
    Pages i-x
  2. S. Cingarlini, M. Bonomi, C. Trentin, V. Corbo, A. Scarpa, G. Tortora
    Pages 9-27
  3. Alexandre Teulé, Laura Martín, Oriol Casanovas
    Pages 29-41
  4. Cindy Neuzillet, Olivia Hentic, Eric Raymond, Philippe Ruszniewski
    Pages 43-63
  5. Jacques Belghiti, Sébastien Gaujoux, Marleny Figueiredo, David Fuks, Alain Sauvanet
    Pages 77-93
  6. Magaly Zappa, Annie Sibert, Mohamed Abdel-Rehim, Olivia Hentic, Marie-Pierre Vullierme, Philippe Ruszniewski et al.
    Pages 95-114
  7. Cindy Neuzillet, Sandrine Faivre, Pascal Hammel, Chantal Dreyer, Eric Raymond
    Pages 127-140
  8. L. Carter, R. A. Hubner, J. W. Valle
    Pages 141-154
  9. Maxime Ronot, Chantal Dreyer, Olivia Hentic, Magaly Zappa, Cristian Mateescu, Anne Couvelard et al.
    Pages 155-165
  10. Annemilaï Tijeras-Raballand, Cindy Neuzillet, Anne Couvelard, Maria Serova, Armand de Gramont, Pascal Hammel et al.
    Pages 167-180
  11. Marta Benavent, Amparo Sanchez-Gastaldo, Rocio Garcia-Carbonero
    Pages 181-198
  12. Geertrui Mertens, Saskia Carton, Chris Verslype, Eric Van Cutsem
    Pages 221-236

About this book


This book pursues a multidisciplinary approach, presenting chapters with updated information on various aspects of treatment for patients with neuroendocrine tumors. Authors have been selected from expert centers in Europe and the United States. The goal of this book is to comprehensively summarize recent data and provide inspiring ideas to optimize the care of patients with neuroendocrine tumors.


Neuroendocrine tumors are fascinating multifaceted diseases that can primarily localize in many organs with various presentations. These tumors are rare but their increasing incidence renders likely that physicians caring for cancers may have either already faced or may be certainly exposed to diagnose and/or treat a patient with neuroendocrine tumors. Over the last years, novel therapeutic options have emerged for neuroendocrine tumors, profoundly challenging practices that had previously been the standards for decades. These include - but are not limited to - somatostatin analogues, targeted therapies such as tyrosine kinase and mTOR inhibitors, antiangiogenic compounds, but also peptide-receptor targeted therapy or radioembolization. This changing field has generated novel treatment algorithms to guide medical decisions. To better understand and handle the multidisciplinary approaches that are required for optimizing the care of neuroendocrine tumor patients, physicians are now looking for references from experts and comprehensive reviews summarizing current knowledge on treatments for patients with neuroendocrine tumors.


Angiogenesis Carcinoid Pancreatic neuroendocrine tumors Somatostatin receptors Tyrosine kinase inhibitors

Editors and affiliations

  • Eric Raymond
    • 1
  • Sandrine Faivre
    • 2
  • Philippe Ruszniewski
    • 3
  1. 1.Medical OncologyBichat-Beaujon University HospitalsClichy cedexFrance
  2. 2.Bichat-Beaujon University Hospitals Medical OncologyClichy cedexFrance
  3. 3.PancreatologyBichat-Beaujon University Hospitals Gastroenterology andClichy cedexFrance

Bibliographic information

Industry Sectors
Health & Hospitals
Oncology & Hematology